131I therapy

You have access
Radioiodine Ablation of Remaining Thyroid Lobe in Patients with Differentiated Thyroid Cancer Treated by Lobectomy: A Systematic Review and Metaanalysis
Arnoldo Piccardo, Pierpaolo Trimboli, Gianluca Bottoni and Luca Giovanella

Journal of Nuclear Medicine December 1, 2020, 61 (12) 1730-1735; DOI: https://doi.org/10.2967/jnumed.120.244384
You have access
Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After ¹³¹I Therapy for Thyroid Cancer
Di Wu, Cristiane J. Gomes Lima, Gary Bloom, Kenneth D. Burman, Leonard Wartofsky and Douglas Van Nostrand

Journal of Nuclear Medicine March 1, 2020, 61 (3) 397-404; DOI: https://doi.org/10.2967/jnumed.119.230730
You have access
Detection at Public Facilities of ¹³¹I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients
Athanasios Bikas, Di Wu, Evelyn Bethancourt, Michael Orquiza, Gary Bloom, Kenneth D. Burman, Leonard Wartofsky and Douglas Van Nostrand

Journal of Nuclear Medicine May 1, 2019, 60 (5) 638-643; DOI: https://doi.org/10.2967/jnumed.118.213256
You have access
Risk of Breast Cancer in Patients with Thyroid Cancer Receiving or Not Receiving ¹³¹I Treatment: A Nationwide Population-Based Cohort Study
Chun-Yi Lin, Cheng-Li Lin, Wen-Sheng Huang and Chia-Hung Kao

Journal of Nuclear Medicine May 1, 2016, 57 (5) 685-690; DOI: https://doi.org/10.2967/jnumed.115.164830

Main menu

User menu

Search

131I therapy